10.11.2015
- A federal district court judge in New York has ruled that Mylan can continue its hostile takeover bid for Perrigo. In the case heard by the court, Perrigo claimed Mylan had made...
11.09.2015
- Following approval from the US Food and Drug Administration (FDA), Netherlands-domiciled Mylan has launched generic copies of Bayer's drospirenone and ethinyl estradiol-based...
10.09.2015
- Mylan has announced a fresh $27.14 billion offer for generic drug and ingredients maker Perrigo. The Ireland-based drugmaker previously rejected several offers from its Netherlands...
02.09.2015
- Fresh from completing its acquisition of GlaxoSmithKline’s OTC business, Ireland-domiciled pharmaceutical producer Perrigo has acquired ScarAway, a leading OTC scar management...
30.07.2015
- July this year began with the highest-ever value of M&A transactions announced in any July since 2008, says Mergermarket, an independent Mergers and Acquisitions (M&A) intelligence...
30.07.2015
- In the latest spectacular takeover to occupy the attention of the international pharmaceuticals sector, Israeli generics giant Teva has agreed to pay $40.5 billion cash and stock...
18.06.2015
- Sandoz, Inc., the US arm of Novartis’ generic drugs division, is asking the Supreme Court of the US state of Mississippi to reverse a county court’s $38.2 million judgment against...
09.06.2015
- Israeli generics giant Teva appears to be seeking alternative strategies for achieving its targeted acquisition of Netherlands-based Mylan, following the company’s rejection of its...
